MMV 18th call for proposals -2020

MMV welcomes proposals in the following areas:

1. Compounds having activity against blood stages and ideally an inability to select resistant mutants in vitro
2. Compounds having activity against liver stages for use in prophylaxis
3. Compounds addressing the key priorities of the malaria eradication agenda
4. Novel approaches for screening

Funding and duration not specified. 

Research Authority due date: 19.3.20

LOI (required) due date: 27.3.20
Full proposal upon request only.